TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 30th July, 2020 at 06:00 P.M. to discuss the financial performance of the Company for the quarter ended 30th June, 2020. TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholding for the Period Ended June 30, 2020
Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2020 ,inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-20. the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-20. TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2020 ,inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-20. TORRENT PHARMACEUTICALS LTD. - 500420 - Updates on Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 09, 2020 for Torrent Pvt Ltd TORRENT PHARMACEUTICALS LTD. - 500420 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 09, 2020 for Torrent Pvt Ltd TORRENT PHARMACEUTICALS LTD. - 500420 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copies of Newspaper cuttings published in ''Financial Express'' (English and Gujarati) on 6th July, 2020 in connection with the 47th Annual General Meeting and E-Voting Procedure. Kindly take note of the above. TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report
Please find enclosed herewith soft copy of the Annual Report 2019-20 (comprising of Notice calling 47th Annual General Meeting along with Audited Financial Statements, Directors' Report, Auditors, Report, etc) of Torrent Pharmaceuticals Limited in compliance with Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding intimation of the 47th AGM of the Company through VC / OAVM facility